Open Access
Vet. Res.
Volume 41, Number 2, March–April 2010
Number of page(s) 15
Published online 20 October 2009
How to cite this article Vet. Res. (2010) 41:13
References of  Vet. Res. (2010) 41:13
  1. Anderson G.G., Dodson K.W., Hooton T.M., Hultgren S.J., Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis, Trends Microbiol. (2004) 12:424–430 [CrossRef] [PubMed].
  2. Bannerman D.D., Paape M.J., Lee J.W., Zhao X., Hope J.C., Rainard P., Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection, Clin. Diagn. Lab. Immunol. (2004) 11:463–472 [CrossRef] [PubMed].
  3. Bannerman D.D., Paape M.J., Hare W.R., Hope J.C., Characterization of the bovine innate immune response to intramammary infection with Klebsiella pneumoniae, J. Dairy Sci. (2004) 87:2420–2432 [PubMed].
  4. Bannerman D.D., Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows, J. Anim. Sci. (2008) 87:10–25 [CrossRef] [PubMed].
  5. Barkema H.W., Schukken Y.H., Lam T.J.G.M., Beiboer M.L., Wilmink H., Benedictus G., Brand A., Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts, J. Dairy Sci. (1998) 81:411–419 [PubMed].
  6. Bergsten G., Wullt B., Svanborg C., Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract, Int. J. Med. Microbiol. (2005) 295:487–502 [CrossRef] [PubMed].
  7. Berry R.E., Klumpp D.J., Schaeffer A.J., Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli, Infect. Immun. (2009) 77:2762–2772 [CrossRef] [PubMed].
  8. Burvenich C., Van Merris V., Mehrzad J., Diez-Fraile A., Duchateau L., Severity of E. coli mastitis is mainly determined by cow factors, Vet. Res. (2003) 34:521–564 [CrossRef] [PubMed] [EDP Sciences].
  9. Burvenich C., Monfardini E., Mehrzad J., Capuco A.V., Paape M.J., Role of neutrophil polymorphonuclear leukocytes during bovine coliform mastitis: physiology or pathology?, Verh. K. Acad. Geneeskd. Belg. (2004) 66:97–150 [PubMed].
  10. Detilleux J., Vangroenweghe F., Burvenich C., Mathematical model of the acute inflammatory response to Escherichia coli in intramammary challenge, J. Dairy Sci. (2006) 89:3455–3465 [PubMed].
  11. Dogan B., Klaessig S., Rishniw M., Almeida R., Oliver S.P., Simpson K.W., Schukken Y.H., Adherent and Invasive Escherichia coli are associated with persistent bovine mastitis, Vet. Microbiol. (2006) 116:270–282 [CrossRef] [PubMed].
  12. Döpfer D., Barkema H.W., Lam T.J.G.M., Schukken Y.H., Gaastra W., Recurrent clinical mastitis caused by Escherichia coli in dairy cows, J. Dairy Sci. (1999) 82:80–85 [PubMed].
  13. Dosogne H., Vangroenweghe F., Mehrzad J., Massart-Leen A.M., Burvenich C., Differential leukocyte count method for bovine low somatic cell count milk, J. Dairy Sci. (2003) 86:828–834 [PubMed].
  14. Franco A.V., Recurrent urinary tract infections, Best Pract. Res. Clin. Obstet. Gynaecol. (2005) 19:861–873 [CrossRef] [PubMed].
  15. Green M.J., Green L.E., Medley G.F., Schukken Y.H., Bradley A.J., Influence of dry period bacterial intramammary infection on clinical mastitis in dairy cows, J. Dairy Sci. (2002) 85:2589–2599 [PubMed].
  16. Iwahi T., Imada A., Interaction of Escherichia coli with polymorphonuclear leukocytes in pathogenesis of urinary tract infection in mice, Infect. Immun. (1988) 56:947–953 [PubMed].
  17. Kirschner D., Marino S., Mycobacterium tuberculosis as viewed through a computer, Trends Microbiol. (2005) 13:206–211 [CrossRef] [PubMed].
  18. Kornalijnslijper J.E., van Werven T., Daemen A.J., van den Broek J., Niewold T.A., Rutten V.P., Noordhuizen-Stassen E.N., In vitro growth of mastitis-inducing Escherichia coli in milk and milk fractions of dairy cows, Vet. Microbiol. (2003) 91:125–134 [CrossRef] [PubMed].
  19. Kornalijnslijper J.E., Daemen A.J., van Werven T., Niewold T.A., Rutten V.P., Noordhuizen-Stassen E.N., Bacterial growth during the early phase of infection determines the severity of experimental Escherichia coli mastitis in dairy cows,Vet. Microbiol. (2004) 101:177–186.
  20. Lohuis J.A., Schukken Y.H., Henricks P.A., Heyneman R., Burvenich C., Verheijden J.H., et al., Preinfection functions of blood polymorphonuclear leukocytes and the outcome of experimental Escherichia coli mastitis in the cow, J. Dairy Sci. (1990) 73:342–350 [PubMed].
  21. Mulvey M.A., Schilling J.D., Hultgren S.J., Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection, Infect. Immun. (2001) 69:4572–4579 [CrossRef] [PubMed].
  22. Olde Riekerink R.G., Barkema H.W., Kelton D.F., Scholl D.T., Incidence rate of clinical mastitis on Canadian dairy farms, J. Dairy Sci. (2008) 91:1366–1377 [CrossRef] [PubMed].
  23. Paape M., Mehrzad J., Zhao X., Detilleux J., Burvenich C., Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes, J. Mammary Gland. Biol. Neoplasia (2002) 7:109–121 [CrossRef] [PubMed].
  24. Saad A.M., Ostensson K., Flow cytofluorometric studies on the alteration of leukocyte populations in blood and milk during endotoxin-induced mastitis in cows, Am. J. Vet. Res. (1990) 51:1603–1607 [PubMed].
  25. Schepers A.J., Lam T.J., Schukken Y.H., Wilmink J.B., Hanekamp W.J., Estimation of variance components for somatic cell counts to determine thresholds for uninfected quarters, J. Dairy Sci. (1997) 80:1833–1840 [PubMed].
  26. Schukken Y.H., Grommers F.J., Vandegeer D., Brand A., Incidence of clinical mastitis on farms with low somatic-cell counts in bulk milk, Vet. Rec. (1989) 125:60–63 [PubMed].
  27. VanWerven T., NoordhuizenStassen E.N., Daemen A.J., Schukken Y.H., Brand A., Burvenich C., Preinfection in vitro chemotaxis, phagocytosis, oxidative burst, and expression of CD11/CD18 receptors and their predictive capacity on the outcome of mastitis induced in dairy cows with Escherichia coli, J. Dairy Sci. (1997) 80:67–74 [PubMed].
  28. Wearing H.J., Rohani P., Keeling M.J., Appropriate models for the management of infectious diseases, PLoS Med. (2005) 2:e174.
  29. Wilson D.J., Grohn Y.T., Bennett G.J., Gonza'lez R.N., Schukken Y.H., Spatz J., Comparison of J5 vaccinates and controls for incidence, etiologic agent, clinical severity, and survival in the herd following naturally occurring cases of clinical mastitis, J. Dairy Sci. (2007) 90:4282–4288 [CrossRef] [PubMed].